Keyphrases
High-dose Chemotherapy
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Relapsed or Refractory
100%
Primary Mediastinal Large B-cell Lymphoma
100%
Vorinostat
57%
Hazard Ratio
42%
Rituximab
42%
Progression-free Survival
28%
Radiation Therapy
28%
Multivariable
14%
Overall Survival
14%
Overall Survival Rate
14%
Gemcitabine
14%
Busulfan
14%
Non-Hodgkin Lymphoma
14%
Positron Emission Tomography
14%
Salvage Chemotherapy
14%
Improved Outcomes
14%
Melphalan
14%
Chemoimmunotherapy
14%
Frontline Therapy
14%
Relapsed Disease
14%
Mediastinal Radiation
14%
Medicine and Dentistry
High Dose Chemotherapy
100%
Autologous Stem Cell Transplantation
100%
Large-Cell Lymphoma
100%
Vorinostat
57%
Hazard Ratio
42%
Rituximab
42%
Overall Survival
28%
Radiation Therapy
28%
Progression Free Survival
28%
Diseases
14%
Survival Rate
14%
Gemcitabine
14%
Non-Hodgkin Lymphoma
14%
positron emission tomographic scan
14%
Busulfan
14%
Melphalan
14%
Chemoimmunotherapy
14%